HIV Immunosuppression and Antimalarial Efficacy: Sulfadoxine‐Pyrimethamine for the Treatment of Uncomplicated Malaria in HIV‐Infected Adults in Siaya, Kenya
Author(s) -
Snehal Shah,
Eric E. Smith,
Charles Obonyo,
Kevin C. Kain,
Peter Bloland,
Laurence Slutsker,
Mary J. Hamel
Publication year - 2006
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/508892
Subject(s) - medicine , malaria , parasitemia , hazard ratio , anemia , immunology , immunosuppression , sulfadoxine/pyrimethamine , sulfadoxine , pyrimethamine , plasmodium falciparum , confidence interval
The altered immune response of persons with human immunodeficiency virus (HIV) infection could result in increased rates of antimalarial treatment failure. We investigated the influence of HIV infection on the response to sulfadoxine-pyrimethamine treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom